Shorter duration of breastfeeding at elevated exposures to perfluoroalkyl substances

Reproductive Toxicology

Volumn 68, Issue , 2017, Pages 164-170

  Timmermann, Clara Amalie Gade ^a   Budtz Jørgensen, Esben ^b   Petersen, Maria Skaalum ^c   Weihe, Pál ^c,d   Steuerwald, Ulrike ^c   Nielsen, Flemming ^a   Jensen, Tina Kold ^a   Grandjean, Philippe ^a,e  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c Department of Occupational Medicine and Public Health ^*  (Denmark)

^d UNIVERSITY OF THE FAROE ISLANDS   (Faroe Islands)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Breast milk; Breastfeeding; Endocrine disruption; Lactation; Maternal health; Perfluoroalkyl substances

Indexed keywords

ENVIRONMENTAL, INDUSTRIAL AND DOMESTIC CHEMICALS; PERFLUOROALKYL SUBSTANCE; PERFLUOROOCTANESULFONIC ACID; PERFLUOROOCTANOIC ACID; UNCLASSIFIED DRUG; ALKANESULFONIC ACID; FLUOROCARBON;

ADULT; ARTICLE; BIOLOGICAL MONITORING; BREAST FEEDING; CHEMICAL ANALYSIS; COHORT ANALYSIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; FEMALE; HUMAN; MATERNAL BLOOD; MULTIPARA; OUTCOME ASSESSMENT; PREGNANCY; PRIMIPARA; BLOOD; DENMARK; MATERNAL EXPOSURE; NEWBORN; POLLUTANT; TIME FACTOR; TRENDS;

ALKANESULFONIC ACIDS; BREAST FEEDING; COHORT STUDIES; DENMARK; ENVIRONMENTAL POLLUTANTS; FEMALE; FLUOROCARBONS; HUMANS; INFANT, NEWBORN; MATERNAL EXPOSURE; TIME FACTORS;

EID: 84979573900     PISSN: 08906238     EISSN: 18731708     Source Type: Journal    
DOI: 10.1016/j.reprotox.2016.07.010     Document Type: Article

References (43)

1. [1] Victora, C.G., Bahl, R., Barros, A.J., Franca, G.V., Horton, S., Krasevec, J., Murch, S., Sankar, M.J., Walker, N., Rollins, N.C., Lancet Breastfeeding Series Group, Breastfeeding in the 21st century: epidemiology, mechanisms, and lifelong effect. Lancet 387:10017 (2016), 475–490.
2. [2] WHO, The Optimal Duration of Exclusive Breastfeeding. 2001, World Health Organization (WHO), Geneva.
3. [3] UNICEF, The State of the World's Children 2015: Executive Summary. 2014, United Nations Children's Fund (UNICEF), New York.
4. [4] Wolf, J.H., Low breastfeeding rates and public health in the United States. Am. J. Public Health 93:12 (2003), 2000–2010.
5. [5] Stuebe, A.M., Horton, B.J., Chetwynd, E., Watkins, S., Grewen, K., Meltzer-Brody, S., Prevalence and risk factors for early undesired weaning attributed to lactation dysfunction. J. Womens Health: Larchmt 23:5 (2014), 404–412.
6. [6] Wambach, K., Campbell, S.H., Gill, S.L., Dodgson, J.E., Abiona, T.C., Heinig, M.J., Clinical lactation practice: 20 years of evidence. J. Hum. Lact. 21:3 (2005), 245–258.
7. [7] Ahluwalia, I.B., Morrow, B., Hsia, J., Why do women stop breastfeeding? Findings from the pregnancy risk assessment and monitoring system. Pediatrics 116:6 (2005), 1408–1412.
8. [8] Li, R., Fein, S.B., Chen, J., Grummer-Strawn, L.M., Why mothers stop breastfeeding: mothers' self-reported reasons for stopping during the first year. Pediatrics 122:Suppl. 2 (2008), S69–S76.
9. [9] Thulier, D., Mercer, J., Variables associated with breastfeeding duration. J. Obstet. Gynecol. Neonatal Nurs. 38:3 (2009), 259–268.
10. [10] Bergmann, R.L., Bergmann, K.E., von Weizsacker, K., Berns, M., Henrich, W., Dudenhausen, J.W., Breastfeeding is natural but not always easy: intervention for common medical problems of breastfeeding mothers—a review of the scientific evidence. J. Perinat. Med. 42:1 (2014), 9–18.
11. [11] Rogan, W.J., Gladen, B.C., McKinney, J.D., Carreras, N., Hardy, P., Thullen, J., Tingelstad, J., Tully, M., Polychlorinated biphenyls (PCBs) and dichlorodiphenyl dichloroethene (DDE) in human milk: effects on growth, morbidity, and duration of lactation. Am. J. Public Health 77:10 (1987), 1294–1297.
12. [12] Gladen, B.C., Rogan, W.J., DDE and shortened duration of lactation in a northern Mexican town. Am. J. Public Health 85:4 (1995), 504–508.
13. [13] Fromme, H., Tittlemier, S.A., Volkel, W., Wilhelm, M., Twardella, D., Perfluorinated compounds?exposure assessment for the general population in western countries. Int. J. Hyg. Environ. Health 212:3 (2009), 239–270.
14. [14] Houde, M., Martin, J.W., Letcher, R.J., Solomon, K.R., Muir, D.C., Biological monitoring of polyfluoroalkyl substances: a review. Environ. Sci. Technol. 40:11 (2006), 3463–3473.
15. [15] Perez, F., Nadal, M., Navarro-Ortega, A., Fabrega, F., Domingo, J.L., Barcelo, D., Farre, M., Accumulation of perfluoroalkyl substances in human tissues. Environ. Int. 59 (2013), 354–362.
16. [16] Grandjean, P., Clapp, R., Perfluorinated alkyl substances: emerging insights into health risks. New Solut. 25:2 (2015), 147–163.
17. [17] Fei, C., McLaughlin, J.K., Lipworth, L., Olsen, J., Maternal concentrations of perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) and duration of breastfeeding. Scand. J. Work. Environ. Health 36:5 (2010), 413–421.
18. [18] Heilmann, C., Budtz-Jorgensen, E., Nielsen, F., Heinzow, B., Weihe, P., Grandjean, P., Serum concentrations of antibodies against vaccine toxoids in children exposed perinatally to immunotoxicants. Environ. Health Perspect. 118:10 (2010), 1434–1438.
19. [19] Grandjean, P., Poulsen, L.K., Heilmann, C., Steuerwald, U., Weihe, P., Allergy and sensitization during childhood associated with prenatal and lactational exposure to marine pollutants. Environ. Health Perspect. 118:10 (2010), 1429–1433.
20. [20] Timmermann, C.A., Osuna, C.E., Steuerwald, U., Weihe, P., Poulsen, L.K., Grandjean, P., Asthma and allergy in children with and without prior measles, mumps, and rubella vaccination. Pediatr. Allergy Immunol. 26:8 (2015), 742–749.
21. [21] Kim, B.M., Choi, A.L., Ha, E.H., Pedersen, L., Nielsen, F., Weihe, P., Hong, Y.C., Budtz-Jorgensen, E., Grandjean, P., Effect of hemoglobin adjustment on the precision of mercury concentrations in maternal and cord blood. Environ. Res. 132 (2014), 407–412.
22. [22] WHO, e-Library of Evidence for Nutrition Actions (eLENA) Exclusive Breastfeeding. 2016, World Health Organization (WHO), Geneva.
23. [23] Eriksson, U., Karrman, A., Rotander, A., Mikkelsen, B., Dam, M., Perfluoroalkyl substances (PFASs) in food and water from Faroe Islands. Environ. Sci. Pollut. Res. Int. 20:11 (2013), 7940–7948.
24. [24] Grandjean, P., Andersen, E.W., Budtz-Jorgensen, E., Nielsen, F., Molbak, K., Weihe, P., Heilmann, C., Serum vaccine antibody concentrations in children exposed to perfluorinated compounds. JAMA 307:4 (2012), 391–397.
25. [25] Brantsaeter, A.L., Whitworth, K.W., Ydersbond, T.A., Haug, L.S., Haugen, M., Knutsen, H.K., Thomsen, C., Meltzer, H.M., Becher, G., Sabaredzovic, A., Hoppin, J.A., Eggesbo, M., Longnecker, M.P., Determinants of plasma concentrations of perfluoroalkyl substances in pregnant Norwegian women. Environ. Int. 54 (2013), 74–84.
26. [26] Berg, V., Nost, T.H., Huber, S., Rylander, C., Hansen, S., Veyhe, A.S., Fuskevag, O.M., Odland, J.O., Sandanger, T.M., Maternal serum concentrations of per- and polyfluoroalkyl substances and their predictors in years with reduced production and use. Environ. Int. 69 (2014), 58–66.
27. [27] Kato, K., Wong, L.Y., Chen, A., Dunbar, C., Webster, G.M., Lanphear, B.P., Calafat, A.M., Changes in serum concentrations of maternal poly- and perfluoroalkyl substances over the course of pregnancy and predictors of exposure in a multiethnic cohort of Cincinnati, Ohio pregnant women during 2003–2006. Environ. Sci. Technol. 48:16 (2014), 9600–9608.
28. [28] Jain, R.B., Contribution of diet and other factors to the levels of selected polyfluorinated compounds: data from NHANES 2003–2008. Int. J. Hyg. Environ. Health 217:1 (2014), 52–61.
29. [29] Sagiv, S.K., Rifas-Shiman, S.L., Webster, T.F., Mora, A.M., Harris, M.H., Calafat, A.M., Ye, X., Gillman, M.W., Oken, E., Sociodemographic and perinatal predictors of early pregnancy per- and polyfluoroalkyl substance (PFAS) concentrations. Environ. Sci. Technol. 49:19 (2015), 11849–11858.
30. [30] Pearl, J., Causal diagrams for empirical research. Biometrika 82:4 (1995), 669–688.
31. [31] Hernan, M.A., Hernandez-Diaz, S., Werler, M.M., Mitchell, A.A., Causal knowledge as a prerequisite for confounding evaluation: an application to birth defects epidemiology. Am. J. Epidemiol. 155:2 (2002), 176–184.
32. [32] Romano, M.E., Xu, Y., Calafat, A.M., Yolton, K., Chen, A., Webster, G.M., Eliot, M.N., Howard, C.R., Lanphear, B.P., Maternal serum perfluoroalkyl substances during pregnancy and duration of breastfeeding. Environ. Res., 2016 (in press).
33. [33] Bach, C.C., Henriksen, T.B., Bossi, R., Bech, B.H., Fuglsang, J., Olsen, J., Nohr, E.A., Perfluoroalkyl acid concentrations in blood samples subjected to transportation and processing delay. PLoS One, 10(9), 2015, e0137768.
34. [34] Jensen, T.K., Andersen, L.B., Kyhl, H.B., Nielsen, F., Christesen, H.T., Grandjean, P., Association between perfluorinated compound exposure and miscarriage in Danish pregnant women. PLoS One, 10(4), 2015, e0123496.
35. [35] Braun, J.M., Chen, A., Romano, M.E., Calafat, A.M., Webster, G.M., Yolton, K., Lanphear, B.P., Prenatal perfluoroalkyl substance exposure and child adiposity at 8 years of age: the HOME study. Obesity: Silver Spring 24:1 (2016), 231–237.
36. [36] White, S.S., Calafat, A.M., Kuklenyik, Z., Villanueva, L., Zehr, R.D., Helfant, L., Strynar, M.J., Lindstrom, A.B., Thibodeaux, J.R., Wood, C., Fenton, S.E., Gestational PFOA exposure of mice is associated with altered mammary gland development in dams and female offspring. Toxicol. Sci. 96:1 (2007), 133–144.
37. [37] White, S.S., Stanko, J.P., Kato, K., Calafat, A.M., Hines, E.P., Fenton, S.E., Gestational and chronic low-dose PFOA exposures and mammary gland growth and differentiation in three generations of CD-1 mice. Environ. Health Perspect. 119:8 (2011), 1070–1076.
38. [38] White, S.S., Kato, K., Jia, L.T., Basden, B.J., Calafat, A.M., Hines, E.P., Stanko, J.P., Wolf, C.J., Abbott, B.D., Fenton, S.E., Effects of perfluorooctanoic acid on mouse mammary gland development and differentiation resulting from cross-foster and restricted gestational exposures. Reprod. Toxicol. 27:3–4 (2009), 289–298.
39. [39] Yang, C., Tan, Y.S., Harkema, J.R., Haslam, S.Z., Differential effects of peripubertal exposure to perfluorooctanoic acid on mammary gland development in C57Bl/6 and Balb/c mouse strains. Reprod. Toxicol. 27:3–4 (2009), 299–306.
40. [40] Lee, C.K., Kang, S.G., Lee, J.T., Lee, S.W., Kim, J.H., Kim, D.H., Son, B.C., Kim, K.H., Suh, C.H., Kim, S.Y., Park, Y.B., Effects of perfluorooctane sulfuric acid on placental PRL-family hormone production and fetal growth retardation in mice. Mol. Cell. Endocrinol. 401 (2015), 165–172.
41. [41] Grandjean, P., Budtz-Jorgensen, E., Steuerwald, U., Heinzow, B., Needham, L.L., Jorgensen, P.J., Weihe, P., Attenuated growth of breast-fed children exposed to increased concentrations of methylmercury and polychlorinated biphenyls. FASEB J. 17:6 (2003), 699–701.
42. [42] Glynn, A., Berger, U., Bignert, A., Ullah, S., Aune, M., Lignell, S., Darnerud, P.O., Perfluorinated alkyl acids in blood serum from primiparous women in Sweden: serial sampling during pregnancy and nursing, and temporal trends 1996–2010. Environ. Sci. Technol. 46:16 (2012), 9071–9079.
43. [43] Mogensen, U.B., Grandjean, P., Nielsen, F., Weihe, P., Budtz-Jorgensen, E., Breastfeeding as an exposure pathway for perfluorinated alkylates. Environ. Sci. Technol. 49:17 (2015), 10466–10473.